This observational study is looking at how well the Symplicity Spyral™ renal denervation (RDN) system works to lower blood pressure in people with uncontrolled high blood pressure (hypertension). RDN is a procedure that uses a device to treat nerves in the kidney. Researchers will compare changes in your office blood pressure after two years if you receive Symplicity Spyral™ RDN plus your usual care, versus just usual care alone. This study uses existing medical records and insurance claims data, so you would not have any extra appointments or procedures. You may be eligible if you are enrolled in Medicare, have uncontrolled high blood pressure, and are already taking blood pressure medication. The study aims to enroll 1000 participants, but its current status is unclear.

Study design

This is an observational study comparing 1000 Medicare patients who receive the Symplicity RDN system plus standard care to similar patients receiving standard care alone.

What's involved

This study uses existing medical records and insurance claims data. You would not have any extra appointments, procedures, or tests.

Compensation

Not stated in the trial record.

Follow-up

Researchers will look at your blood pressure changes and major adverse cardiac events over a two-year period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.